Blood Pressure and Polymorphisms of Α-and Β-Adducin Genes in a White Population
JG Wang,JA Staessen,C Barlassina,RH Fagard,L Tizzoni,G Bianchi
DOI: https://doi.org/10.1016/s0895-7061(02)02693-6
2002-01-01
American Journal of Hypertension
Abstract:We investigated the single and combined effects of the α-adducin Gly460Trp and the β-adducin C1797T polymorphisms on blood pressure (BP), plasma renin activity (PRA) and urinary excretion of sodium, potassium and aldosterone in a white population. We randomly recruited 1847 subjects. Study nurses measured BP at subjects’ home. We also measured PRA and urinary excretion of sodium, potassium and aldosterone, and genotyped our subjects for the α-adducin Gly460Trp and β-adducin C1797T polymorphisms. Median age was 41 years (range 10-84) and systolic/diastolic BP averaged 123/76 mm Hg. The sample included 944 (51.1%) women and 423 (22.9) hypertensive patients, of whom 212 (11.5) were on antihypertensive drug treatment. The α-adducin Trp and β-adducin T allele frequencies were 0.23 and 0.11, respectively. In single-gene analyses with adjustment for sex, age, body-mass index, smoking, alcohol intake, and use of antihypertensive drugs or oral contraceptives, none of the genetic associations with BP or the biochemical measurements reached statistical significance. Further analyses showed that BP varied depending on whether none, one or two mutations were present (ANOVA, P=0.03 and P=0.04), with highest systolic and diastolic BP in carriers of the two mutated alleles (α-adducin 460Trp and β-adducin 1797T allele). The combined genetic effect on BP was age-dependent. In the upper quartile of the age distribution (55-84 years), systolic and diastolic BPs were, respectively, 4.6 mm Hg (P=0.09) and 4.0 mm Hg (P=0.007) higher in carriers of Trp and T alleles than subjects who were homozygous for Gly or C allele. After exclusion of patients treated with drugs known to affect the renin system, there was an independent inverse correlation between PRA and BP in subjects carrying both Trp and T alleles (SBP: partial r=-0.37, P<0.001; DBP: partial r=-0.17, P=0.09). Because there was a significant interaction with age, the partial correlation coefficients between PRA and BP were highly significant in carriers of two mutated alleles, who were above median age (SBP: partial r=-0.52, P<0.001; DBP: partial r=-0.44, P=0.005). In conclusion, our findings suggest that mutations of the α- and β-subunits of the heterodimeric cytoskeleton protein adducin and age interact to affect BP. We speculate that in older compared with younger subjects inhibition of PRA is pathophysiologically more important in compensating for the volume expansion and increase in BP in carriers of mutated adducin.